GlassScriptPhysician profile
David John Cohen
NPI 1861499337
$3,992.95
in general payments reported to CMS, 2019-2025
15 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.21 · 2020: $23.91 · 2021: $141 · 2022: $16.94 · 2023: $1,290 · 2024: $2,276 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $970 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $969.75 |
| Travel and Lodging | $782.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guard Medical INC. | $2,000.00 | 2024 | Npseal Large |
| Abbott Laboratories | $1,192.23 | 2023-2024 | Mitraclip, Optis |
| Convatec INC. | $257.23 | 2023-2024 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2021 | |
| Paratek Pharmaceuticals, INC. | $124.99 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $61.45 | 2020-2025 | Renasys Touch, Renasys Go V2 Home |
| Atricure, INC. | $58.21 | 2019 | |
| Edwards Lifesciences Corporation | $35.78 | 2023 | |
| Esperion Therapeutics, INC. | $33.27 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $22.44 | 2023 | Farxiga |
| Solventum Corporation | $20.49 | 2025 | Activ.A.C., V.A.C. Granufoam, Snap |
| Hydrofera LLC | $19.14 | 2024 | Cutimed Sorbion |
| Hartmann USA, INC. | $16.90 | 2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $13.83 | 2023 | Tcc-Ez |
| Reprise Biomedical, INC. | $12.00 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.